πŸ‡ΊπŸ‡Έ FDA
Patent

US 11312749

Heterotandem bicyclic peptide complex

granted A61KA61K38/00A61K38/12

Quick answer

US patent 11312749 (Heterotandem bicyclic peptide complex) held by BicycleTx Limited expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleTx Limited
Grant date
Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61K38/12, A61K47/641, A61K9/0019